New Non-Steroid eye shot could ease blurry vision

NCT ID NCT06825702

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new eye injection called KIO-104 for people with macular edema, a condition where fluid builds up in the eye and blurs vision. About 28 adults will receive multiple doses to see if the drug is safe and helps reduce swelling. The goal is to find a steroid-free option for treating this eye problem.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
KIO-104 (a non-steroidal eye injection)
What this could lead to
If successful, this could lead to a new treatment option for macular edema that avoids steroids and their side effects.
What could go wrong
This is an early Phase 2 trial with only 28 participants, so results may not apply to everyone. The drug is still being tested for safety and may not improve vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Centre for Eye Research Australia

    RECRUITING

    East Melbourne, Victoria, 3002, Australia

  • Hobart Eye Surgeons

    RECRUITING

    Hobart, Tasmania, 7000, Australia

  • Lions Eye Institute Limited

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

    Contact Email: •••••@•••••

  • Royal Adelaide Hospital

    NOT_YET_RECRUITING

    Adelaide, South Australia, 5000, Australia

  • Sydney Eye Hospital

    RECRUITING

    Sydney, New South Wales, 2001, Australia

  • Sydney West Retina

    NOT_YET_RECRUITING

    Westmead, New South Wales, 2145, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.